LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

Fei Teng(University of Chinese Academy of Sciences), Zhiqiu Hu(Fudan University)
Journal of Experimental & Clinical Cancer Research
November 9, 2020
Cited by 154


Related Papers